Patients receiving systemic therapy must be monitored according to which drug is used.
Patients treated with biologic agents require monitoring mainly for infections.[66]O'Neill ID, Scully C. Biologics in oral medicine: principles of use and practical considerations. Oral Dis. 2012 Sep;18(6):525-36.
https://onlinelibrary.wiley.com/doi/10.1111/j.1601-0825.2012.01919.x
http://www.ncbi.nlm.nih.gov/pubmed/22420757?tool=bestpractice.com
[67]O'Neill ID, Scully C. Biologics in oral medicine: ulcerative disorders. Oral Dis. 2013 Jan;19(1):37-45.
http://www.ncbi.nlm.nih.gov/pubmed/22471882?tool=bestpractice.com